Institute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, Germany.
Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2265-2273. doi: 10.1016/j.jaip.2023.06.027. Epub 2023 Jun 23.
Chronic urticaria is a disease that can significantly impact a patient's quality of life and ability to function. There are effective treatment options, such as nonsedating antihistamines or biologics, but some patients do not respond to these therapies, or the therapies are not available or affordable to all patients. This review aims to summarize potential treatment strategies for patients (1) who do not respond to antihistamines and (2) cannot readily access or do not respond to biologics. The review emphasizes the importance of sound clinical practice, including correct diagnosis of chronic urticaria phenotypes, treatment of associated comorbidities, and consideration of add-on pharmacological and nonpharmacological approaches. Although some treatments may lack high-quality evidence, they may still be justifiable in certain cases, provided that there is shared decision-making, regular reassessment, and early recognition of adverse events.
慢性荨麻疹是一种会显著影响患者生活质量和功能的疾病。有一些有效的治疗方法,如非镇静性抗组胺药或生物制剂,但有些患者对这些疗法没有反应,或者这些疗法对所有患者都不可用或负担不起。本综述旨在总结对(1)对抗组胺药无反应和(2)无法轻易获得或对生物制剂无反应的患者的潜在治疗策略。本综述强调了正确的临床实践的重要性,包括对慢性荨麻疹表型的正确诊断、对相关合并症的治疗以及对附加药物和非药物方法的考虑。虽然一些治疗方法可能缺乏高质量的证据,但在某些情况下,只要有共同决策、定期重新评估和早期识别不良事件,它们仍可能是合理的。